New treatment option for Prosthesis and Implant Dentistry
Official title Passive Fit of Implant-Supported Complete-Arch Prostheses Using Digital Workflows
ClinicalTrials.gov ID: NCT07315620
What this study is testing
- What it's testing
- The goal of this clinical trial is to evaluate and compare three digital workflows for the fabrication of definitive implant-supported full-arch prostheses in adult patients requiring fixed implant rehabilitation. The main questions it aims to answer are: Does an automated AI-assisted digital workflow improve the passive fit of definitive full-arch implant-supported prostheses compared with manual and splint-guided alignment workflows?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults aged 18 years or older.
- Patients indicated for fixed implant-supported full-arch rehabilitation in the maxilla or mandible.
- Presence of clinically stable, osteointegrated titanium implants suitable for prosthetic rehabilitation.
- Absence of clinical or radiographic signs of peri-implant disease.
- Ability to understand the study procedures and provide written informed consent.
You likely can't join if
- Presence of peri-implant mucositis or peri-implantitis at the time of evaluation.
- Implant mobility or implant positioning that prevents proper prosthetic rehabilitation.
- Uncontrolled systemic medical conditions that could interfere with study participation or prosthetic treatment.
- Cognitive, psychological, or medical conditions that limit the ability to comply with study procedures.
- Inability to complete the required clinical evaluations or follow the study protocol, as judged by the investigator.
See the full eligibility criteria
- Adults aged 18 years or older.
- Patients indicated for fixed implant-supported full-arch rehabilitation in the maxilla or mandible.
- Presence of clinically stable, osteointegrated titanium implants suitable for prosthetic rehabilitation.
- Absence of clinical or radiographic signs of peri-implant disease.
- Ability to understand the study procedures and provide written informed consent.
- Willingness and ability to attend all required clinical visits and evaluations.
- Presence of peri-implant mucositis or peri-implantitis at the time of evaluation.
- Implant mobility or implant positioning that prevents proper prosthetic rehabilitation.
- Uncontrolled systemic medical conditions that could interfere with study participation or prosthetic treatment.
- Cognitive, psychological, or medical conditions that limit the ability to comply with study procedures.
- Inability to complete the required clinical evaluations or follow the study protocol, as judged by the investigator.
The study team makes the final eligibility decision.
Where it's taking place
- Madrid, Madrid, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Madrid, Madrid, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.